ID: ALA4225462

Max Phase: Preclinical

Molecular Formula: C25H26F3N5O5

Molecular Weight: 533.51

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1cc(C(=O)N2CCC(NC(=O)c3ccccc3OC(F)(F)F)c3c2cnn3C(C)C)cnc1OC

Standard InChI:  InChI=1S/C25H26F3N5O5/c1-14(2)33-21-17(31-22(34)16-7-5-6-8-19(16)38-25(26,27)28)9-10-32(18(21)13-30-33)24(35)15-11-20(36-3)23(37-4)29-12-15/h5-8,11-14,17H,9-10H2,1-4H3,(H,31,34)

Standard InChI Key:  MOKGQUKWOUYHHS-UHFFFAOYSA-N

Associated Targets(Human)

Serine palmitoyltransferase 2 14 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HCC4006 24 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mus musculus 284745 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 533.51Molecular Weight (Monoisotopic): 533.1886AlogP: 4.30#Rotatable Bonds: 7
Polar Surface Area: 107.81Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.20CX Basic pKa: 2.13CX LogP: 3.29CX LogD: 3.29
Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.48Np Likeness Score: -1.42

References

1. Kojima T, Asano Y, Kurasawa O, Hirata Y, Iwamura N, Wong TT, Saito B, Tanaka Y, Arai R, Yonemori K, Miyamoto Y, Sagiya Y, Yaguchi M, Shibata S, Mizutani A, Sano O, Adachi R, Satomi Y, Hirayama M, Aoyama K, Hiura Y, Kiba A, Kitamura S, Imamura S..  (2018)  Discovery of novel serine palmitoyltransferase inhibitors as cancer therapeutic agents.,  26  (9): [PMID:29669694] [10.1016/j.bmc.2018.04.008]

Source